Physician profile
Gerald B Harris
NPI 1689676165
$5,044.53
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,518 · 2020: $793 · 2021: $1,191 · 2022: $1,543.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $835.97 | 2019-2022 | |
| Indivior INC. | $472.22 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $439.06 | 2019-2022 | |
| Medtronic, INC. | $361.35 | 2021-2022 | |
| Mdd US Operations, LLC | $325.02 | 2019-2020 | |
| Orexo US, INC. | $320.83 | 2019-2022 | |
| Antares Pharma, INC. | $316.73 | 2021-2022 | |
| Lucid Diagnostics INC. | $299.80 | 2021-2022 | |
| Abbvie INC. | $291.83 | 2021-2022 | |
| Novo Nordisk INC | $245.50 | 2019-2022 | |
| Lilly USA, LLC | $204.16 | 2020-2022 | |
| Spinal Simplicity, LLC | $136.47 | 2022 | |
| Uswm, LLC | $117.86 | 2021-2022 | |
| Pfizer INC. | $93.91 | 2019-2021 | |
| Covidien LP | $86.85 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $81.47 | 2022 | |
| Medtronic USA, INC. | $71.95 | 2019 | |
| Abbott Laboratories | $71.65 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $42.39 | 2019 | |
| Daiichi Sankyo INC. | $24.64 | 2021 | |
| Allergan, INC. | $22.55 | 2020 | |
| Alkermes, INC. | $19.07 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.42 | 2022 | |
| Esperion Therapeutics, INC. | $17.98 | 2021 | |
| Titan Pharmaceuticals, INC. | $17.78 | 2019 | |
| Eisai INC. | $17.30 | 2021 | |
| Alfasigma USA, INC. | $15.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.93 | 2022 | |
| Boston Scientific Corporation | $13.20 | 2019 | |
| Horizon Therapeutics Plc | $12.68 | 2019 | |
| Merck Sharp & Dohme LLC | $12.57 | 2019 | |
| Biodelivery Sciences International, INC. | $11.86 | 2019 | |
| Acerus Pharmaceuticals Corporation | $11.71 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.